Anna Maria Zanellato

This inventor holds 15 USPTO granted patents and 1 published patent application, plus 7 CIPO patents and 11 EPO patents. Top assignee: Fidia Farmaceutici S.p.a.. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anna Maria Zanellato. Retrieved from https://idiyas.com/inventor/anna-maria-zanellato

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 1)

% Patents Active = 86.7

CIPO Patents = 7 (Patent Applications = 2)

EPO Patents = 11 (Patent Applications = 10)

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 16(Granted Patents)

Location History:

Padua, IT (2008)
Albano Terme, IT (2014)
Bovolenta, IT (2010 - 2019)
Abano Terme, IT (2017 - 2023)

Company Filing History:

15 out of 88

Fidia Farmaceutici S.p.a.

patents

Years Active: 2008-2026

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12721862 - Pharmaceutical composition for use in the treatment of cystitis of various etiologies (2026-09-01),

2. 12447134 - Multilayer composite material (2025-10-21),

3. 11684588 - Multilayer composite material (2023-06-27),

4. 11197886 - Pharmaceutical compositions with hydrating and lubricating activity (2021-12-14),

5. 10821131 - Pharmaceutical formulations comprising chondroitin sulfate and hyaluronic acid derivatives (2020-11-03),

6. 10548918 - Sulphated hyaluronic acids as regulator agents of the cytokine activity (2020-02-04),

7. 10478413 - Dermal therapeutic system with high adhesivity (2019-11-19),

8. 9962349 - Dermal therapeutic system with high adhesivity (2018-05-08),

9. 9808482 - Sulphated hyaluronic acids as regulator agents of the cytokine activity (2017-11-07),

10. 9655918 - Pharmaceutical formulations comprising chondroitin sulfate and hyaluronic acid derivatives (2017-05-23),

11. 8771672 - Biological material suitable for the therapy of osteoarthrosis, ligament damage and for the treatment of joint disorders (2014-07-08),

12. 8178663 - Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring (2012-05-15),

13. 8178499 - Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring (2012-05-15),

14. 7759095 - Process for the preparation and isolation of phosphatides (2010-07-20),

15. 7462606 - Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring (2008-12-09),

Title: **The Innovations of Anna Maria Zanellato: A Trailblazer in Pharmaceutical Patents**

Introduction

Anna Maria Zanellato, an accomplished inventor based in Abano Terme, Italy, has made significant contributions to the field of pharmaceuticals with an impressive portfolio of 13 patents. Her work focuses on developing advanced materials and formulations that address critical health issues, particularly related to wound care and women's health.

Latest Patents

Among her latest innovations, one notable patent is for a **multilayer composite material** designed specifically for the treatment of wounds and lesions. This advanced dressing incorporates a multilayer material that enhances healing processes. Another significant invention is her pharmaceutical composition featuring **ester derivatives of hyaluronic acid**. This composition is intended for topical treatments of vaginal mucosa disorders characterized by loss of elasticity and hydration, including vaginal dryness and atrophic vaginitis. The versatility of this formulation also allows it to effectively lubricate the genital mucosa.

Career Highlights

Anna Maria currently works at Fidia Farmaceutici S.p.a., where she continues to drive innovation in pharmaceutical products. Her extensive experience and knowledge have positioned her as a leader in the industry, making her inventions vital for improving patient care and quality of life.

Collaborations

Throughout her career, Anna Maria has collaborated with esteemed colleagues such as Giovanni Gennari and Davide Bellini. These partnerships have not only fostered a creative environment for innovative ideas but have also led to the development of groundbreaking products that push the boundaries of pharmaceutical science.

Conclusion

The contributions of Anna Maria Zanellato highlight the essential role of inventors in advancing healthcare solutions. Her dedication to research and innovation, exemplified through her multiple patents, underscores the importance of continued investment in pharmaceutical inventions for the betterment of society. Her work at Fidia Farmaceutici S.p.a. serves as an inspiration to aspiring inventors and a testament to the impact that focused innovation can have on healthcare.

Profile summary based on public USPTO records.